[{"AccountsPayableCurrent_0_Q1_USD":7841000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":10409000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":108766000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":11506000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":363000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":62902000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":777000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":258000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":856000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-624000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-624000.0,"OtherAssetsNoncurrent_0_Q1_USD":92000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1069000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":18834000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":15958000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3469000.0,"OperatingIncomeLoss_1_Q1_USD":-30409000.0,"NonoperatingIncomeExpense_1_Q1_USD":258000.0,"NetIncomeLoss_1_Q1_USD":-30115000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-13271000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":45501000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":9632000.0,"ProfitLoss_1_Q1_USD":-30115000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":5435000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":48549000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":608000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":10409000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":248000.0,"StockholdersEquity_0_Q1_USD":384384000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":75.32,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":65.88,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":42.11,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":52.74,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":4177000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":97158000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":52.74,"LiabilityForUncertainTaxPositionsNoncurrent_0_Q1_USD":520000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":4177000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":607000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":34000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":46.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2425000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":71494000.0,"ShareBasedCompensation_1_Q1_USD":6062000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":15559000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":27648000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":18461000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q1_USD":-777000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":97158000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":20388000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":1506000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":440594000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":99068000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":46000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":88668000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":159984000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":248652000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":249274000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":654000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":32000.0,"AssetsFairValueDisclosure_0_Q1_USD":334837000.0,"AssetsCurrent_0_Q1_USD":326957000.0,"Assets_0_Q1_USD":440594000.0,"AssetRetirementObligationsNoncurrent_0_Q1_USD":336000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":2843000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":6062000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":6062000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":366724000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-1006000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":569000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":26580000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-546000.0,"AccountsReceivableNetCurrent_0_Q1_USD":27648000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":99676000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":41862000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"Liabilities_0_Q1_USD":56210000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-2682000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":298000.0,"IncreaseDecreaseInIncomeTaxesReceivable_1_Q1_USD":-8504000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":4206000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":4072000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-1663000.0,"IncomeTaxReceivable_0_Q1_USD":28751000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-36000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-30151000.0,"LiabilitiesCurrent_0_Q1_USD":37890000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":9508000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2423000.0,"EarningsPerShareDiluted_1_Q1_USD":-1.48,"EarningsPerShareBasic_1_Q1_USD":-1.48,"DepreciationAndAmortization_1_Q1_USD":780000.0,"CostsAndExpenses_1_Q1_USD":58057000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-30739000.0,"CommonStockValue_0_Q1_USD":205000.0,"CommonStockSharesOutstanding_0_Q1_shares":20506000.0,"CommonStockSharesIssued_0_Q1_shares":20506000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":71254000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":20388000.0,"Ticker":"ENTA","CIK":"1177648","name":"ENANTA PHARMACEUTICALS INC","OfficialName":"Enanta Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20211231","fy":"2022.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1492537180.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20220210"}]